Intra-Cellular Therapies Ownership | Who Owns Intra-Cellular Therapies?
Intra-Cellular Therapies Ownership Summary
Intra-Cellular Therapies is owned by 99.44% institutional investors, 2.33% insiders. Fmr is the largest institutional shareholder, holding 11.60% of ITCI shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.69% of its assets in Intra-Cellular Therapies shares.
ITCI Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Intra-Cellular Therapies | 99.44% | 2.33% | -1.77% |
Sector | Healthcare Stocks | 47.31% | 8.01% | 44.69% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 33.38% | 9.20% | 57.42% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 11.24M | 11.60% | $769.68M |
Vanguard group | 9.61M | 9.92% | $657.98M |
Blackrock | 6.32M | 6.53% | $432.97M |
Wasatch advisors lp | 3.72M | 3.84% | $254.66M |
Jpmorgan chase | 3.44M | 3.55% | $235.28M |
Avoro capital advisors | 3.00M | 3.10% | $205.47M |
Invesco | 2.94M | 3.03% | $201.18M |
Bellevue group | 2.47M | 2.55% | $169.26M |
Norges bank | 1.94M | 2.01% | $133.13M |
State street | 1.80M | 1.86% | $123.44M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Altium capital management lp | 193.00K | 5.39% | $13.22M |
Suvretta capital management | 1.57M | 3.94% | $107.26M |
First turn management | 347.34K | 3.87% | $23.79M |
Dcf advisers | 100.51K | 3.55% | $6.88M |
Silverarc capital management | 192.34K | 3.11% | $13.17M |
Artia global partners lp | 216.52K | 2.87% | $14.83M |
Perceptive advisors | 1.72M | 2.79% | $117.56M |
Bellevue group | 2.47M | 2.75% | $169.26M |
Avoro capital advisors | 3.00M | 2.74% | $205.47M |
Tang capital management | 300.00K | 2.09% | $20.55M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Norges bank | 1.94M | 0.02% | 1.94M |
Jpmorgan chase | 3.44M | 0.02% | 1.68M |
Alyeska investment group | 1.39M | 0.55% | 1.14M |
Westfield capital management co lp | 1.04M | 0.35% | 1.04M |
Invesco | 2.94M | 0.04% | 864.37K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 6.32M | 0.01% | -1.76M |
Avidity partners management lp | - | - | -600.00K |
Macquarie group | 1.01M | 0.08% | -451.11K |
State street | 1.80M | 0.01% | -438.44K |
Wellington management group llp | 1.25M | 0.02% | -408.97K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 1.94M | 0.02% | 1.94M | $133.13M |
Westfield capital management co lp | 1.04M | 0.35% | 1.04M | $71.43M |
Hood river capital management | 487.52K | 0.69% | 487.52K | $33.39M |
Driehaus capital management | 215.44K | 0.14% | 215.44K | $14.76M |
Moody aldrich partners | 99.01K | 1.32% | 99.01K | $6.78M |
Sold Out
Holder | Change |
---|---|
Sanctuary wealth management | -1.00 |
Financial gravity asset management | -1.00 |
Continuum advisory | -6.00 |
Financial synergies wealth advisors | -6.00 |
International assets investment management | -12.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 378 | 3.00% | 96,330,666 | 10.68% | 99 | 1.21% | 210 | 19.32% | 127 | - |
Mar 31, 2024 | 367 | 5.16% | 87,032,607 | -2.57% | 90 | 1.05% | 176 | -3.83% | 127 | 11.40% |
Dec 31, 2023 | 349 | 15.95% | 89,328,831 | 3.75% | 92 | 1.15% | 183 | 12.96% | 114 | 26.67% |
Sep 30, 2023 | 301 | 1.69% | 86,097,281 | 2.30% | 89 | 1.15% | 162 | -1.82% | 90 | 11.11% |
Jun 30, 2023 | 296 | 2.78% | 84,160,996 | 0.64% | 88 | 1.14% | 165 | 11.49% | 81 | -8.99% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl O | 3.90M | 3.69% | -95.00K |
Fidelity Growth Compy Commingled Pl S | 3.89M | 3.67% | -14.37K |
Vanguard Total Stock Mkt Idx Inv | 3.20M | 3.02% | -13.99K |
Fidelity Growth Company Fund | 2.88M | 2.71% | -45.39K |
Vanguard Small Cap Index | 2.52M | 2.37% | 4.95K |
BB Biotech AG Ord | 2.47M | 2.34% | 20.00K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.48M | 1.39% | -22.20K |
Vanguard Small Cap Growth Index Inv | 1.38M | 1.30% | -3.79K |
JPM US Mid Cap Growth-Composite | 1.32M | 1.25% | 137.29K |
JPMorgan Mid Cap Growth I | 1.32M | 1.24% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 12, 2024 | Halstead Michael | President | Sell | $548.18K |
Nov 12, 2024 | Halstead Michael | President | Sell | $149.79K |
Nov 12, 2024 | Halstead Michael | President | Sell | $1.34M |
Nov 13, 2024 | Halstead Michael | President | Sell | $1.18M |
Nov 13, 2024 | Halstead Michael | President | Sell | $475.10K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 5 |
2024 Q3 | - | 17 |
2024 Q2 | - | 3 |
2024 Q1 | - | 73 |
2023 Q4 | - | 5 |
ITCI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools